BSEInsider Trading / SAST7h ago · 25 Sept 2026, 12:23 pm

Intimation of closure of Trading Window wef October 1, 2026

Fischer Medical Ventures Ltd · 524743

✦ AI Summary

Fischer Medical Ventures Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter ended September 30, 2026, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fischer Medical Ventures Ltd - 524743 - Closure of Trading Window

Attachments (1)

📄

34f34c5b-21a7-4697-aca6-69cd150d422f.pdf

pdf

Download →
View document text
FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 Date: 25/09/2026 To To BSE Limited National Stock Exchange of India Ltd. Exchange Corporate Relationship Department Plaza, 5tll floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001 Mumbai - 400 051 Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir / Madam, Sub: Closure of Trading Window This is to inform that, as per the Company's code of conduct for Prohibition of Insider Trading and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the Company’s equity shares by the Promoters /Directors / Designated persons will remain closed from October 01, 2026 till 48 hours after the declaration of Un-Audited Financial Results for the quarter ended September 30, 2026. Intimation regarding the notice of Board Meeting to be held to consider and approve the Un-Audited Financial Results for the quarter ended September 30, 2026 shall be sent separately to the Stock Exchanges. Further, the designated persons and their immediate relatives have been intimated not to trade in the securities of the Company during the above said period of closure of trading window. This is for your kind information and records. Kindly acknowledge receipt. Thanking You, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY & COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006